International Women's Day 2021
Support Burnet’s work to help women and girls impacted by COVID-19.
Support Burnet’s work to help women and girls impacted by COVID-19.
Support Burnet’s work to help women and girls impacted by COVID-19.
Support Burnet’s work to help women and girls impacted by COVID-19.
The Antiviral Screening Facility has the capacity to test chemical agents that will inhibit the replication of HIV and herpes simplex (HSV) type 1 and 2 viruses in cell culture assays. This means that researchers can accelerate the development of new molecules that may lead to better treatments for these chronic infections.
The team has extensive experience in basic research and in particular in understanding the biology of retroviruses. Their expertise is highly regarded and all work undertaken by the facility is done using principles outlined in the FDA guidelines for Antiviral Product Development.
For any general enquiries relating to this facility, please contact:
Head of Life Sciences; Head of Tachedjian Laboratory (Retroviral Biology and Antivirals)